Acute Heart FailureAlexandre Mebazaa, Mihai Gheorghiade, Faiez Zannad, Joseph E. Parrillo For many years, there has been a great deal of work done on chronic congestive heart failure while acute heart failure has been considered a difficult to handle and hopeless syndrome. However, in recent years acute heart failure has become a growing area of study. There has been considerable amounts of new data reported and many new concepts have been proposed in the last 3-4 years looking at the epidemiology, diagnostic and treatment of acute heart failure. |
What people are saying - Write a review
We haven't found any reviews in the usual places.
Contents
5 | |
7 | |
13 | |
20 | |
Peculiarities of Acute Heart Failure Syndromes in Latin America and the Role of Chagas Disease | 30 |
Normal Physiology and Pathophysiology of Left Ventricular Systole | 43 |
Normal Physiology and Pathophysiology of Left Ventricular Diastole | 52 |
Normal Physiology and Pathophysiology of the Right Ventricle | 63 |
Noninvasive Ventilation and Acute Heart Failure Syndrome | 477 |
Invasive Ventilation and Acute Heart Failure Syndrome | 486 |
Chest XRay in Acute Heart Failure | 494 |
Management of Volume Overload in Acute Heart Failure Diuretics and Ultrafiltration | 503 |
Role of Anemia in Acute and Chronic Heart Failure and the Role of Erythropoietin in Its Correction | 519 |
Management of Chronic Heart Failure Therapy in the Setting of Acute Heart Failure | 533 |
Nitrates in Acute Decompensated Heart Failure | 545 |
Use of Nesiritide in the Management Algorithm of Acute Decompensated Heart Failure | 551 |
Myocardial Protection from Ischemia and Reperfusion Injury | 70 |
Receptor Signaling Pathways in Heart Failure Transgenic Mouse Models | 89 |
Acute Heart Failure and Cardiac Remodeling | 112 |
Reactive Oxygen Species in Heart Failure | 118 |
Mitochondrion Key Factors in Acute Heart Failure | 124 |
Immune System Alterations in Acute Heart Failure | 134 |
Organ Perfusion in Acute Heart Failure Syndromes | 148 |
Dyspnea How to Differentiate Between Acute Heart Failure Syndrome and Other Diseases | 161 |
Acute Heart Failure in the Setting of Acute Coronary Syndromes | 168 |
Acute Heart Failure and Myocarditis | 183 |
Management of Severe Acute Heart Failure | 200 |
Cardiogenic Shock | 207 |
Arrhythmia in Acute Heart Failure | 221 |
Right Ventricular Dysfunction in the Intensive Care Unit | 237 |
Acute Pericardial Disease | 247 |
Acute Pericardial Disease Pericardiocentesis and Percutaneous Pericardiotomy | 255 |
Severe Cardiac Disease in Pregnancy | 269 |
Acute Heart Failure Syndromes and Endocrine Disorders | 291 |
Acute Heart Failure Syndromes in bThalassemia | 297 |
Acute Heart Failure and Systemic Diseases | 306 |
Acute Heart Failure in the Postoperative Period | 323 |
Myocardial Dysfunction in Sepsis and Septic Shock | 333 |
Acute Heart Failure Syndromes and Drug Intoxication | 348 |
SleepRelated Breathing Disorders and Acute Heart Failure Syndrome | 359 |
Acute Heart Failure Syndromes in the Elderly | 371 |
Acute Heart Failure Syndromes in Neonatal and Pediatric Populations | 378 |
Esophageal Doppler Noninvasive Estimation of Stroke Volume | 391 |
Minimally Invasive Cardiac Output Monitoring Pulse Contour and Pulse Power Analysis | 397 |
Oxygen Saturation Measurements in Acute Heart Failure Syndrome | 406 |
Pulmonary Artery Catheter in the Intensive Care Unit | 411 |
Assessment of Critically Ill Patients with Acute Heart Failure Syndromes Using Echocardiography Doppler | 424 |
Portable Echocardiography and Acute Heart Failure Syndromes in the Emergency Room | 446 |
Coronary Angiography in Acute Heart Failure | 451 |
Arterial Blood Gas Analysis in Acute Heart Failure Syndrome | 455 |
BType Natriuretic Peptide Testing in the Emergency Room and Intensive Care Unit for the Patient with Acute Heart Failure | 468 |
Dobutamine in the Management of Acute Heart Failure Syndrome | 567 |
Therapeutic Role of Dopamine in Acute Heart Failure Syndrome | 577 |
Vasopressors in Acute Severe Heart Failure | 583 |
Calcium Sensitizer Levosimendan and Its Use in Acute Heart Failure and Related Conditions | 595 |
Natriuretic Peptides | 608 |
Vasopressin Antagonists in Acute Heart Failure Syndromes | 621 |
Endothelin Receptor Antagonists and Acute Heart Failure Syndromes | 626 |
Antiplatelets and Anticoagulation in the Setting of Acute Heart Failure Syndrome | 639 |
Successful Analgesia and Sedation for Patients with Acute Heart Failure Syndromes | 655 |
Intraaortic Balloon Pump in the Management of Acute Heart Failure Syndromes | 671 |
Cardiac Resynchronization Therapy in Acute and Chronic Heart Failure Syndromes | 684 |
Acute Heart Failure Treatment and Brain Protection | 692 |
EndofLife Care for Critically Ill Patients with Heart Failure A Multidisciplinary Viewpoint from the Intensive Care Unit | 704 |
Anesthesia for Patients with Acute Heart Failure Syndromes | 719 |
Mechanical Circulatory Support for Management of Cardiogenic Shock Beyond Intraaortic Balloon Pump Support and Inotropes | 730 |
Role of Left Ventricular Assist Devices in Acute Heart Failure Syndrome and the Future of the Replacement Heart | 737 |
Kidney in Acute Heart Failure | 751 |
Acute Hypoxic Hepatitis and Hepatic Consequences of Acute Heart Failure Syndrome | 763 |
Lactate and Acute Heart Failure Syndrome | 768 |
Glucose Disturbance and Acute Heart Failure Syndrome | 781 |
Hyponatremia in the Setting of Acute Heart Failure Syndrome | 786 |
Pulmonary Disease in the Setting of Acute Heart Failure Syndrome | 797 |
Mechanical Devices to Improve Circulation During Cardiopulmonary Resuscitation | 809 |
Pharmacology in Cardiopulmonary Resuscitation | 819 |
Role of Automated External Defibrillators in Acute Heart Failure Patients | 827 |
PostCardiopulmonary Resuscitation Management in the Intensive Care Unit | 837 |
Role of the Pharmacist in the Management of Acute Heart Failure Syndrome | 847 |
Role of Nursing in the Management of Acute Heart Failure Syndromes | 857 |
Psychological Support in Acute Heart Failure Syndrome | 867 |
Nutrition in Acute Decompensation of Patients with Acute Heart Failure Syndrome | 876 |
Classification of the Level of Evidence in International Guidelines for Acute and Chronic Heart Failure | 885 |
Drug Development for Acute Heart Failure Syndromes European Regulatory View | 892 |
Drug Approval Process for Acute Heart Failure Syndrome in the United States | 899 |
909 | |
Other editions - View all
Acute Heart Failure Alexandre Mebazaa,Mihai Gheorghiade,Faiez Zannad,Joseph E. Parrillo No preview available - 2007 |
Acute Heart Failure Alexandre Mebazaa,Mihai Gheorghiade,Faiez Zannad,Joseph E. Parrillo No preview available - 2016 |
Common terms and phrases
abnormalities activation acute decompensated heart acute heart failure acute myocardial infarction afterload aortic arrhythmias associated balloon blood flow blood pressure Ca2+ cardiac output cardiogenic shock cardiomyopathy cardiovascular catheter cell chronic heart failure Circulation Clin clinical congestive heart failure contractility coronary artery Crit decompensated heart failure decrease diagnosis diastolic dilated diuretics dobutamine dopamine Doppler dose drugs dysfunction dyspnea echocardiography effects ejection fraction factors filling pressures fluid function Heart Failure Syndrome heart rate hemodynamic hospital hypertension hypertrophy hypotension IABP improve increased infusion inotropic intravenous ischemia ischemic JAm Coll Cardiol left ventricular levosimendan loop diuretics mechanical metabolic milrinone mitral mortality myocyte natriuretic peptide nesiritide normal oxygen patients with acute perfusion pericardial pregnancy preload protein pulmonary artery pulmonary edema pump receptor reduced renal reperfusion respiratory right ventricular risk septic shock symptoms systemic systolic tamponade therapy tion treatment trial vascular vasodilation vasopressin venous ventilation ventricle µg/kg/min